We are live on ! Find out more
MIRM icon

Mirum Pharmaceuticals
MIRM

67 hedge funds and large institutions have $405M invested in Mirum Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 21 increasing their positions, 23 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

233% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 3

10% more funds holding

Funds holding: 61 → 67 (+6)

0.02% more ownership

Funds ownership: 76.83% → 76.86% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

9% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 23

13% less capital invested

Capital invested by funds: $463M → $405M (-$58.6M)

Holders
67
Holders Change
+6
Holders Change %
+9.84%
% of All Funds
1.17%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
10
Increased
21
Reduced
23
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$4.27M
2
Axa
Axa
France
+$1.66M
3
Renaissance Technologies
Renaissance Technologies
New York
+$885K
4
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$885K
5
Morgan Stanley
Morgan Stanley
New York
+$798K

Top Sellers

Rank Fund Capital Flow
1
SI
Sofinnova Investments
California
-$3.89M
2
BlackRock
BlackRock
New York
-$2.74M
3
DCM
Driehaus Capital Management
Illinois
-$2.56M
4
Millennium Management
Millennium Management
New York
-$679K
5
RJA
Raymond James & Associates
Florida
-$358K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jacobs Levy Equity Management
26
Jacobs Levy Equity Management
New Jersey
$1.26M +$885K +49,394 +212%
CIP
27
Chartwell Investment Partners
Pennsylvania
$1.14M +$10.7K +595 +0.9%
PAM
28
Panagora Asset Management
Massachusetts
$999K -$2.53K -141 -0.2%
Renaissance Technologies
29
Renaissance Technologies
New York
$854K +$885K +49,400 New
Invesco
30
Invesco
Georgia
$818K +$33.3K +1,858 +4%
Morgan Stanley
31
Morgan Stanley
New York
$781K +$798K +44,502 +7,248%
Millennium Management
32
Millennium Management
New York
$778K -$679K -37,871 -46%
AA
33
ALPS Advisors
Colorado
$693K -$267K -14,926 -27%
JP Morgan Chase
34
JP Morgan Chase
New York
$691K +$428K +23,892 +148%
GCP
35
GSA Capital Partners
United Kingdom
$545K -$59.9K -3,344 -10%
HF
36
HRT Financial
New York
$415K +$430K +24,006 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$405K -$62.3K -3,479 -13%
Los Angeles Capital Management
38
Los Angeles Capital Management
California
$362K +$29.9K +1,666 +9%
Point72 Asset Management
39
Point72 Asset Management
Connecticut
$325K +$247K +13,800 +276%
PP
40
PDT Partners
New York
$321K +$332K +18,546 New
AllianceBernstein
41
AllianceBernstein
Tennessee
$289K +$32.3K +1,800 +12%
RJA
42
Raymond James & Associates
Florida
$240K -$358K -20,000 -59%
SO
43
STRS Ohio
Ohio
$235K +$23.3K +1,300 +11%
VEA
44
Virtus ETF Advisers
New York
$218K +$1.56K +87 +0.7%
RIL
45
Rothschild Investment LLC
Illinois
$201K +$208K +11,600 New
N
46
Nuveen
North Carolina
$191K -$59.1K -3,300 -23%
E
47
Ergoteles
New York
$190K +$197K +11,000 New
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$180K -$52.7K -2,942 -22%
ED
49
Exane Derivatives
France
$138K +$155K +8,626 New
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$94K +$896 +50 +0.9%
1
2
3

MIRM Hedge Fund Activity: Q2 2021 in Review

67 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mirum Pharmaceuticals (MIRM) for Q2 2021, worth a combined $405M — down 13% from $463M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new MIRM positions and 3 closed out — a net gain of 7 holders — while 21 added to existing stakes and 23 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $4.27M. The largest seller was Sofinnova Investments, cutting an estimated $3.89M.

  • 67 institutional investors held Mirum Pharmaceuticals (MIRM) as of Q2 2021, up from 61 in Q1 2021.
  • Funds reported $405M of Mirum Pharmaceuticals stock for Q2 2021, down 13% quarter-over-quarter.
  • 10 funds opened new Mirum Pharmaceuticals positions in Q2 2021 and 3 closed out, a net change of +7 holders.
  • The largest Mirum Pharmaceuticals buyer in Q2 2021 was Wellington Management Group, an estimated $4.27M added.
  • The largest Mirum Pharmaceuticals seller in Q2 2021 was Sofinnova Investments, an estimated $3.89M sold.

Based on aggregated 13F filings for Q2 2021.